Research Article
Amtolmetin: A Reappraisal of NSAID with Gastroprotection
Table 2
Demographic profile of the patients from shortlisted studies.
| | Bianchi Porro et al. [8] (4 weeks) | Montrone et al. [6] (30 days) | Jajić et al. [4] (24 weeks) | Age (year) mean ± SD | | AMG | Diclofenac | AMG | Piroxicam | AMG | Celecoxib | AMG | NSAIDs |
| Patients evaluated, | 32 | 32 | 49 | 50 | 85 | 95 | | | Male, (%) | 6 (18.8) | 5 (15.6) | 5 (10.2) | 10 (20) | 18 (21.2) | 21 (22.1) | Female, (%) | 26 (81.2) | 27 (84.4) | 44 (89.8) | 40 (80) | 67 (78.8) | 74 (77.9) |
|
|